补体系统激活与中轴型脊柱关节炎2年随访放射学进展相关:CONSUL RCT发现
在CONSUL随机对照试验中,96例活动性放射学中轴型脊柱关节炎患者启动TNF抑制剂戈利木单抗治疗,基线C3dg和MASP-1升高与新骨形成相关,MASP-3降低;随访时C3dg和L-ficolin升高与新骨形成相关,提示补体激活与放射学脊柱进展相关。
要点
- 基线C3dg和MASP-1升高及MASP-3降低与新骨形成相关,多因素分析仍显著。
- 随访时C3dg和L-ficolin升高与新骨形成相关,C3dg多因素分析仍显著。
- 补体激活标志物可能预测TNFi治疗后的放射学进展。
核心结论
- 补体激活标志物C3dg、MASP-1和MASP-3水平在TNFi治疗前可预测高放射学进展风险axSpA患者2年随访后的新骨形成。
- 随访时L-ficolin和C3dg水平在新骨形成患者中升高。
- 研究结果支持补体系统激活与axSpA放射学脊柱进展相关。
研究设计与样本
- 研究基于多中心随机对照试验CONSUL,纳入96例活动性放射学axSpA患者。
- 患者启动TNF抑制剂戈利木单抗治疗,分析基线及108周后的血清样本。
- 采用免疫分析法检测补体激活标志物C3dg及补体蛋白(MBL、CL-L1、M-、H-和L-ficolin;MASP-1、-2和-3;MAp44)。
主要发现
- 基线时,2年随访后出现新骨形成(新发韧带骨赘和/或现有韧带骨赘增长)的患者总补体激活标志物C3dg和凝集素途径激活蛋白酶MASP-1水平升高,而MASP-3水平降低。
- 单因素logistic回归显示基线MASP-1、MASP-3和C3dg水平与新骨形成相关,并在相应的多因素logistic回归分析中保持显著。
- 随访时,新骨形成患者血清C3dg和补体凝集素途径启动因子L-ficolin水平升高,C3dg在相应的多因素logistic回归分析中保持显著。
临床怎么用
- 基线C3dg、MASP-1和MASP-3水平可能用于识别TNFi治疗后高放射学进展风险的axSpA患者。
- 随访时C3dg和L-ficolin水平升高与新骨形成相关,可作为监测补体激活的参考。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate complement system activation and complement protein levels in relation to radiographic progression in axial spondyloarthritis (axSpA) within a longitudinal randomised controlled trial (RCT) of radiographic axSpA patients initiating tumour necrosis factor inhibitor (TNFi) therapy. METHODS: Serum samples from 96 patients with active radiographic axSpA in the multicentre RCT CONSUL were analysed by immunoassays for complement activation, that is, C3dg and complement proteins (MBL, CL-L1, M-, H- and L-ficolin; MASP-1,-2 and -3; and MAp44) before and after 108 weeks of TNF inhibitor therapy with golimumab. RESULTS: Baseline serum levels of total complement activation, that is, C3dg and lectin pathway activating protease MASP-1 were elevated in patients with new bone formation (new syndesmophytes and/or growth of existing syndesmophytes) after 2 years of follow-up, whereas baseline MASP-3 levels were decreased. Assessed by univariate logistic regression, baseline levels of MASP-1, MASP-3 and C3dg were associated with the development of new bone formation and remained significant in a corresponding multivariate logistic regression analysis. At follow-up, serum levels of C3dg and complement lectin pathway initiator L-ficolin were elevated in patients with new bone formation, and C3dg remained significant in a corresponding multivariate logistic regression analysis. CONCLUSIONS: Complement activation marker C3dg, MASP-1 and MASP-3 levels before TNFi therapy predicted new bone formation after 2 years of follow-up among axSpA patients with a high risk of radiographic progression. Furthermore, levels of L-ficolin and C3dg at follow-up were elevated in axSpA patients with new bone formation. Our findings support an association between activation of the complement system and radiographic spinal progression in patients with axSpA.
引用
- Mistegaard C, Troldborg A, Torgutalp M, et al. Complement system activation is associated with spinal radiographic progression in axial spondyloarthritis after 2 years of follow-up: findings from the CONSUL RCT. RMD Open. 2025. PMID: 41314669. doi:10.1136/rmdopen-2025-006087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。